| Primary |
| Hypercholesterolaemia |
19.0% |
| Drug Use For Unknown Indication |
12.7% |
| Diabetes Mellitus |
9.5% |
| Hypertension |
9.5% |
| Bone Tuberculosis |
6.3% |
| Myocardial Infarction |
6.3% |
| Bronchitis Chronic |
4.8% |
| Renal Transplant |
4.8% |
| Coronary Artery Bypass |
3.2% |
| Dyslipidaemia |
3.2% |
| Embolism |
3.2% |
| Osteoarthritis |
3.2% |
| Psoriasis |
3.2% |
| Angina Pectoris |
1.6% |
| Anxiety |
1.6% |
| Arteritis |
1.6% |
| Atrial Fibrillation |
1.6% |
| Back Pain |
1.6% |
| Benign Prostatic Hyperplasia |
1.6% |
| Bronchial Carcinoma |
1.6% |
|
| Tendonitis |
12.0% |
| Agranulocytosis |
8.0% |
| Pulmonary Embolism |
8.0% |
| Rectal Haemorrhage |
8.0% |
| Transaminases Increased |
8.0% |
| Azoospermia |
4.0% |
| Blood Creatinine Increased |
4.0% |
| Death |
4.0% |
| Diabetes Mellitus |
4.0% |
| Hypoglycaemia |
4.0% |
| Myocardial Infarction |
4.0% |
| Osteoarthritis |
4.0% |
| Pain In Extremity |
4.0% |
| Pancytopenia |
4.0% |
| Pregnancy |
4.0% |
| Renal Impairment |
4.0% |
| Subdural Haematoma |
4.0% |
| Visual Disturbance |
4.0% |
| Vomiting |
4.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
36.6% |
| Hypertension |
10.2% |
| Ill-defined Disorder |
9.8% |
| Hypercholesterolaemia |
7.1% |
| Renal Transplant |
7.1% |
| Pain |
4.1% |
| Hiv Infection |
3.7% |
| Diabetes Mellitus Non-insulin-dependent |
2.7% |
| Dyslipidaemia |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Wolff-parkinson-white Syndrome |
2.4% |
| Angina Pectoris |
1.4% |
| Atrial Fibrillation |
1.4% |
| Bone Tuberculosis |
1.4% |
| Bronchitis Chronic |
1.4% |
| Epilepsy |
1.4% |
| Arterial Stenosis |
1.0% |
| Benign Prostatic Hyperplasia |
1.0% |
| Essential Hypertension |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
|
| Rhabdomyolysis |
14.1% |
| Memory Impairment |
9.9% |
| Tendonitis |
8.5% |
| Interstitial Lung Disease |
7.0% |
| Vomiting |
7.0% |
| Weight Decreased |
7.0% |
| Pyrexia |
5.6% |
| White Blood Cell Count Increased |
5.6% |
| Pancreatitis Acute |
4.2% |
| Ventricular Fibrillation |
4.2% |
| Agranulocytosis |
2.8% |
| Arthralgia |
2.8% |
| Food Poisoning |
2.8% |
| Hepatitis Cholestatic |
2.8% |
| Pancytopenia |
2.8% |
| Status Epilepticus |
2.8% |
| Toxic Skin Eruption |
2.8% |
| Transaminases Increased |
2.8% |
| Varices Oesophageal |
2.8% |
| Amyotrophic Lateral Sclerosis |
1.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
42.2% |
| Hypertension |
11.8% |
| Product Used For Unknown Indication |
7.9% |
| Hypercholesterolaemia |
5.8% |
| Prophylaxis |
4.5% |
| Diabetes Mellitus |
3.0% |
| Pain |
2.6% |
| Osteoporosis |
2.4% |
| Diarrhoea |
2.3% |
| Multiple Myeloma |
2.3% |
| Thrombosis Prophylaxis |
2.1% |
| Atrial Fibrillation |
1.7% |
| Ill-defined Disorder |
1.7% |
| Renal Failure |
1.7% |
| Gastrooesophageal Cancer |
1.5% |
| Neuralgia |
1.5% |
| Back Pain |
1.3% |
| Breast Cancer |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Acute Myeloid Leukaemia |
1.1% |
|
| Renal Failure Acute |
13.6% |
| Thrombocytopenia |
10.7% |
| Renal Failure |
8.7% |
| Vomiting |
6.8% |
| Nausea |
4.9% |
| Pyrexia |
4.9% |
| Toxic Skin Eruption |
4.9% |
| Urinary Retention |
4.9% |
| Weight Decreased |
4.9% |
| Hypertension |
3.9% |
| Malnutrition |
3.9% |
| Retinal Ischaemia |
3.9% |
| Somnolence |
3.9% |
| Death |
2.9% |
| Hypoxia |
2.9% |
| Lung Disorder |
2.9% |
| Pneumonitis |
2.9% |
| Rectal Haemorrhage |
2.9% |
| Syncope |
2.9% |
| Vitamin B12 Deficiency |
2.9% |
|
| Interacting |
|
| Haematoma |
33.3% |
| International Normalised Ratio Increased |
33.3% |
| Pleural Effusion |
33.3% |
|
